Please ensure Javascript is enabled for purposes of website accessibility

SEC Filing Details

Document Details

Filing Date
Apr 18, 2018
Document Date
Apr 18, 2018
Form Description
Registration of up to an additional 20% of securities for any offering registered on an S-1
Filing Group
Registration Statements
Company
Apellis Pharmaceuticals, Inc.
Issuer
APELLIS PHARMACEUTICALS, INC.